ECB-ART-51905
Int J Mol Sci
2022 Jan 21;233:. doi: 10.3390/ijms23031184.
Show Gene links
Show Anatomy links
Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders.
Toledo ARL
,
Monroy GR
,
Salazar FE
,
Lee JY
,
Jain S
,
Yadav H
,
Borlongan CV
.
???displayArticle.abstract???
Human lifestyle and dietary behaviors contribute to disease onset and progression. Neurodegenerative diseases (NDDs), considered multifactorial disorders, have been associated with changes in the gut microbiome. NDDs display pathologies that alter brain functions with a tendency to worsen over time. NDDs are a worldwide health problem; in the US alone, 12 million Americans will suffer from NDDs by 2030. While etiology may vary, the gut microbiome serves as a key element underlying NDD development and prognosis. In particular, an inflammation-associated microbiome plagues NDDs. Conversely, sequestration of this inflammatory microbiome by a correction in the dysbiotic state of the gut may render therapeutic effects on NDDs. To this end, treatment with short-chain fatty acid-producing bacteria, the main metabolites responsible for maintaining gut homeostasis, ameliorates the inflammatory microbiome. This intimate pathological link between the gut and NDDs suggests that the gut-brain axis (GBA) acts as an underexplored area for developing therapies for NDDs. Traditionally, the classification of NDDs depends on their clinical presentation, mostly manifesting as extrapyramidal and pyramidal movement disorders, with neuropathological evaluation at autopsy as the gold standard for diagnosis. In this review, we highlight the evolving notion that GBA stands as an equally sensitive pathological marker of NDDs, particularly in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and chronic stroke. Additionally, GBA represents a potent therapeutic target for treating NDDs.
???displayArticle.pubmedLink??? 35163103
???displayArticle.link??? Int J Mol Sci
???displayArticle.grants??? [+]
R21 AG072379 NIA NIH HHS , R56 AG064075 NIA NIH HHS , R56 AG069676 NIA NIH HHS , RF1 AG071762 NIA NIH HHS
References [+] :
Alessandrini,
Stem cell therapy for neurological disorders.
2019, Pubmed
Alessandrini, Stem cell therapy for neurological disorders. 2019, Pubmed
Altman, Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins. 2021, Pubmed
Arya, Brain-gut axis after stroke. 2018, Pubmed
Atri, The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management. 2019, Pubmed
Baizabal-Carvallo, The Link between Gut Dysbiosis and Neuroinflammation in Parkinson's Disease. 2020, Pubmed
Benakis, The microbiome-gut-brain axis in acute and chronic brain diseases. 2020, Pubmed
Bhuiyan, Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention. 2021, Pubmed
Boddy, The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). 2021, Pubmed
Bonafede, ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles. 2017, Pubmed
Bonsack, A gut feeling about stroke reveals gut-brain axis' active role in homeostasis and dysbiosis. 2020, Pubmed
Borlongan, Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet? 2019, Pubmed
Bostanciklioğlu, The role of gut microbiota in pathogenesis of Alzheimer's disease. 2019, Pubmed
Boulos, Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence? 2019, Pubmed
Brown, Amyotrophic Lateral Sclerosis. 2017, Pubmed
Burberry, C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. 2020, Pubmed
Cabreira, [Parkinson's Disease: Clinical Review and Update]. 2019, Pubmed
Catanese, Acute Ischemic Stroke Therapy Overview. 2017, Pubmed
Chandra, α-Synuclein in gut endocrine cells and its implications for Parkinson's disease. 2017, Pubmed
Checkoway, Neurodegenerative diseases. 2011, Pubmed
Chen, Role of neuroinflammation in neurodegenerative diseases (Review). 2016, Pubmed
Coppedè, One-carbon epigenetics and redox biology of neurodegeneration. 2021, Pubmed
Corey, Stem cell-based regenerative medicine for neurological disorders: A special tribute to Dr. Teng Ma. 2019, Pubmed
Cryan, The gut microbiome in neurological disorders. 2020, Pubmed
D'Mello, Overdosing on iron: Elevated iron and degenerative brain disorders. 2020, Pubmed
Derex, Mechanical thrombectomy in acute ischemic stroke. 2017, Pubmed
Dinan, Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. 2017, Pubmed
Doria, Incidence, Implications, and Management of Seizures Following Ischemic and Hemorrhagic Stroke. 2019, Pubmed
Elmaleh, New Approaches to Profile the Microbiome for Treatment of Neurodegenerative Disease. 2021, Pubmed
Erkkinen, Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. 2018, Pubmed
Farshbafnadi, The second brain: The connection between gut microbiota composition and multiple sclerosis. 2021, Pubmed
Ford, Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges. 2020, Pubmed
Gabbianelli, Epigenetics and neurodegeneration: role of early-life nutrition. 2018, Pubmed
García-Culebras, Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions. 2018, Pubmed
Ghaisas, Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. 2016, Pubmed
Ghezzi, Targeting the gut to treat multiple sclerosis. 2021, Pubmed
Goyal, Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease. 2021, Pubmed
Grad, Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). 2017, Pubmed
Grasselli, Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation. 2018, Pubmed
Gratwicke, Parkinson's disease dementia: a neural networks perspective. 2015, Pubmed
Grenham, Brain-gut-microbe communication in health and disease. 2011, Pubmed
Grochowski, Neural stem cell therapy-Brief review. 2018, Pubmed
Gubert, Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases. 2020, Pubmed
Guerreiro, CD38 in Neurodegeneration and Neuroinflammation. 2020, Pubmed
Guest, Early Diagnosis and Targeted Treatment Strategy for Improved Therapeutic Outcomes in Alzheimer's Disease. 2020, Pubmed
Han, Introduction for Stem Cell-Based Therapy for Neurodegenerative Diseases. 2020, Pubmed
Hane, Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment. 2017, Pubmed
Hardiman, Amyotrophic lateral sclerosis. 2017, Pubmed
Hare, Is early-life iron exposure critical in neurodegeneration? 2015, Pubmed
Heemels, Neurodegenerative diseases. 2016, Pubmed
Henkel, Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. 2004, Pubmed
Hulisz, Amyotrophic lateral sclerosis: disease state overview. 2018, Pubmed
Hwang, The emerging field of epigenetics in neurodegeneration and neuroprotection. 2017, Pubmed
Ibarra, Immunization with neural-derived antigens inhibits lipid peroxidation after spinal cord injury. 2010, Pubmed
Incontri Abraham, Stand alone or join forces? Stem cell therapy for stroke. 2019, Pubmed
Ivan, Gastro-intestinal dysfunctions in Parkinson's disease (Review). 2021, Pubmed
Jackson, Diet in Parkinson's Disease: Critical Role for the Microbiome. 2019, Pubmed
Jankovic, Parkinson's disease: clinical features and diagnosis. 2008, Pubmed
Jayaraj, Neuroinflammation: friend and foe for ischemic stroke. 2019, Pubmed
Jeong, Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease. 2017, Pubmed
Jiang, The Gut Microbiota and Alzheimer's Disease. 2017, Pubmed
Jones, Functions of DNA methylation: islands, start sites, gene bodies and beyond. 2012, Pubmed
Kesika, Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. 2021, Pubmed
Kim, Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI Improves Cognitive and Memory Function in the Mouse Model of Alzheimer's Disease. 2021, Pubmed
Klostranec, Current Concepts in Intracranial Interstitial Fluid Transport and the Glymphatic System: Part II-Imaging Techniques and Clinical Applications. 2021, Pubmed
Kolagar, Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations. 2020, Pubmed
Kong, Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease. 2020, Pubmed
Kovacs, Concepts and classification of neurodegenerative diseases. 2017, Pubmed
Kowalski, Brain-Gut-Microbiota Axis in Alzheimer's Disease. 2019, Pubmed
Lardenoije, The epigenetics of aging and neurodegeneration. 2015, Pubmed
Lee, Stem Cell-Induced Biobridges as Possible Tools to Aid Neuroreconstruction after CNS Injury. 2017, Pubmed
Lee, Histopathological and Behavioral Assessments of Aging Effects on Stem Cell Transplants in an Experimental Traumatic Brain Injury. 2019, Pubmed
Leuzy, Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease. 2022, Pubmed
Lin, Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease. 2019, Pubmed
Liska, Biobridge concept in stem cell therapy for ischemic stroke. 2017, Pubmed
Liu, Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson's disease, especially on bradykinesia. 2017, Pubmed
Lolekha, Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial). 2021, Pubmed
Lubomski, Parkinson's disease and the gastrointestinal microbiome. 2020, Pubmed
Madaro, Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis. 2018, Pubmed
Makris, Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research. 2018, Pubmed
Marefati, Lactation ameliorates neurobehavioral outcomes in the ischemic rat dams. 2022, Pubmed
Marizzoni, Microbiota and neurodegenerative diseases. 2017, Pubmed
Marogianni, Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disease. 2020, Pubmed
Martínez-Iglesias, DNA Methylation in Neurodegenerative and Cerebrovascular Disorders. 2020, Pubmed
Matej, Alzheimer's disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview. 2019, Pubmed
Mazzini, Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies. 2018, Pubmed
McCarthy, Long-Term Outcomes of Mechanical Thrombectomy for Stroke: A Meta-Analysis. 2019, Pubmed
McMillen, Postnatal Iron Supplementation with Ferrous Sulfate vs. Ferrous Bis-Glycinate Chelate: Effects on Iron Metabolism, Growth, and Central Nervous System Development in Sprague Dawley Rat Pups. 2021, Pubmed
Megur, The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame? 2020, Pubmed
Michel, Understanding Dopaminergic Cell Death Pathways in Parkinson Disease. 2016, Pubmed
Miraglia, Microbiome, Parkinson's Disease and Molecular Mimicry. 2019, Pubmed
Mischley, Nutrition and Nonmotor Symptoms of Parkinson's Disease. 2017, Pubmed
Mo, Autophagy and inflammation in ischemic stroke. 2020, Pubmed
Mulak, Brain-gut-microbiota axis in Parkinson's disease. 2015, Pubmed
Narayanan, Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease. 2020, Pubmed
Needham, Gut microbial molecules in behavioural and neurodegenerative conditions. 2020, Pubmed
Nguyen, Stem cell therapy for neurological disorders: A focus on aging. 2019, Pubmed
O'Donnell, Pathophysiology of stroke: what do cells of the neurovascular unit have to do with it? 2019, Pubmed
Obrenovich, The Role of the Microbiota-Gut-Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases. 2020, Pubmed
Onyango, Neuroinflammation in Alzheimer's Disease. 2021, Pubmed
Oskarsson, Amyotrophic Lateral Sclerosis: An Update for 2018. 2018, Pubmed
Perosa, Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex. 2022, Pubmed
Phipps, Management of acute ischemic stroke. 2020, Pubmed
Pluta, Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both? 2021, Pubmed
Qin, Dual Functions of Microglia in Ischemic Stroke. 2019, Pubmed
Quigley, Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. 2017, Pubmed
Rabinstein, Treatment of Acute Ischemic Stroke. 2017, Pubmed
Ralli, Amyotrophic Lateral Sclerosis: Autoimmune Pathogenic Mechanisms, Clinical Features, and Therapeutic Perspectives. 2019, Pubmed
Ridolfi, Neurodegenerative Disorders Treatment: The MicroRNA Role. 2017, Pubmed
Rutsch, The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology. 2020, Pubmed
Sanford, Mild Cognitive Impairment. 2017, Pubmed
Santos-Garcia, [Gastroparesis and other gastrointestinal symptoms in Parkinson's disease]. 2015, Pubmed
Sarikaya, Stroke prevention--medical and lifestyle measures. 2015, Pubmed
Schnell, Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. 2021, Pubmed
Shi, Global brain inflammation in stroke. 2019, Pubmed
Sochocka, The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review. 2019, Pubmed
Spielman, Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases. 2018, Pubmed
Spychala, Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome. 2018, Pubmed
Stan, Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington's disease. 2020, Pubmed
Stonesifer, Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. 2017, Pubmed
Subhramanyam, Microglia-mediated neuroinflammation in neurodegenerative diseases. 2019, Pubmed
Sugaya, Stem Cell Therapies for Neurodegenerative Diseases. 2018, Pubmed
Sun, A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease. 2020, Pubmed
Sun, Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. 2018, Pubmed
Thaiss, The microbiome and innate immunity. 2016, Pubmed
Tilocca, Gut-Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization. 2020, Pubmed
Tomasello, Intestinal innate immune cells in gut homeostasis and immunosurveillance. 2013, Pubmed
Travagli, Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. 2020, Pubmed
Tuazon, Neural Stem Cells. 2019, Pubmed
Ustyantseva, Studying ALS: Current Approaches, Effect on Potential Treatment Strategy. 2020, Pubmed
Vasic, Neurodegeneration and Neuro-Regeneration-Alzheimer's Disease and Stem Cell Therapy. 2019, Pubmed
Vivekanantham, Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair. 2015, Pubmed
Wasser, Gut dysbiosis in Huntington's disease: associations among gut microbiota, cognitive performance and clinical outcomes. 2020, Pubmed
Wegner, Glutamate receptor properties of human mesencephalic neural progenitor cells: NMDA enhances dopaminergic neurogenesis in vitro. 2009, Pubmed
Westfall, Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. 2017, Pubmed
Wheater, DNA methylation and brain structure and function across the life course: A systematic review. 2020, Pubmed
Xu, Microglia-Mediated Inflammation and Neurodegenerative Disease. 2016, Pubmed
Xu, Glial Cells: Role of the Immune Response in Ischemic Stroke. 2020, Pubmed
Yamanaka, The multi-dimensional roles of astrocytes in ALS. 2018, Pubmed
Yang, The Infant Microbiome: Implications for Infant Health and Neurocognitive Development. 2016, Pubmed
Yang, Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. 2019, Pubmed
Zakrzewski, Stem cells: past, present, and future. 2019, Pubmed
Zhang, MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. 2012, Pubmed
Zhao, Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer's Disease (AD). 2015, Pubmed